Study of the efficacy of intravesical instillations of interleukin-2 in treatment of superficial bladder cancer
- Conditions
- Ta,T1 /G1,G2,G3 superficial bladder cancerMedDRA version: 9.1Level: LLTClassification code 10005003Term: Bladder cancer
- Registration Number
- EUCTR2004-002821-30-LT
- Lead Sponsor
- Institute of Oncology, Vilnius University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
1. Signed patient informed consent form
2. Histologically confirmed diagnosis of multifocal Ta,T1 /G1,G2 superficial bladder cancer
3. WHO-performance status 0-2
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
1. The presence of a cancer type other than transitional cell carcinoma
2. Previous intravesical chemotherapy within 3 months before treatment
3. Previous radiotherapy to the bladder
4. Urinary tract infection
5. Decompensated cardiovascular, renal or liver diseases
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method